ArticleJournal of clinical microbiology2011
Fatal invasive infection with fungemia due to Microascus cirrosus after heart and lung transplantation in a patient with cystic fibrosis.
Article in Journal of clinical microbiology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 38 citations in OpenAlex.
- Clinical characterization and etiological insights: a small cohort study of pulmonary infections caused byFrontiers in microbiology · 2025Article
- A comprehensive molecular phylogeny ofPersoonia · 2024Article
- Microbial Pathogens in Aquaponics Potentially Hazardous for Human Health.Microorganisms · 2023Review
- Refractory Microascus Bronchopulmonary Infection Treated with Olorofim, France.Emerging infectious diseases · 2023Article
- Article
- PulmonaryRespiratory medicine case reports · 2021Article
- RNA-Based Analysis Reveals High Diversity of Plant-Associated Active Fungi in the Atmosphere.Frontiers in microbiology · 2021Article
- First reported case of disseminatedIDCases · 2020Article
- Article
- Rapid Assays for Specific Detection of Fungi of Scopulariopsis and Microascus Genera and Scopulariopsis brevicaulis Species.Mycopathologia · 2016Article
- In vitro activities of a wide panel of antifungal drugs against various Scopulariopsis and Microascus species.Antimicrobial agents and chemotherapy · 2015Article
- In Vitro Triple Combination of Antifungal Drugs against Clinical Scopulariopsis and Microascus Species.Antimicrobial agents and chemotherapy · 2015Article
- Fatal Scopulariopsis infection in a lung transplant recipient: lessons of organ procurement.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2014Article
- Sinusitis caused by Scopulariopsis brevicaulis: Case report and review of the literature.Medical mycology case reports · 2014Article
- Scopulariopsis, a poorly known opportunistic fungus: spectrum of species in clinical samples and in vitro responses to antifungal drugs.Journal of clinical microbiology · 2013Article
- Emerging invasive fungal diseases in transplantation.Current infectious disease reports · 2012Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors at 4 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Scopulariopsis species are rarely but increasingly recognized as opportunistic pathogens in immunocompromised patients. We report on a patient suffering from cystic fibrosis who developed disseminated fungal infection due to a rare Scopulariopsis species, Microascus cirrosus, after heart and lung transplantation. Despite antifungal combination therapy with voriconazole and caspofungin, the patient died 4 weeks after transplantation. Diagnostic difficulties and optimal management of disseminated Scopulariopsis/Microascus infections are discussed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.